Blenx models of α-synuclein and parkin kinetics in neuropathology of Parkinson's disease

Journal of Biological Systems

Volumn 19, Issue 2, 2011, Pages 149-181

  Lecca, Paola ^a  

^a UNIVERSITY OF TRENTO   (Italy)

Author keywords

Synuclein; BlenX; CoSBiLab; Parkin; Parkinson's Diseases; Stochastic Simulation

Indexed keywords

EID: 79960371032     PISSN: 02183390     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0218339011003865     Document Type: Article

References (46)

1. Kandel ER, Schwartz J, Jessell T, Principles of Neural Science, McGraw-Hill, Health Professions Division, New York, 2000.
2. Dauer W, Przedborski S, Parkinson's disease: Mechanisms and models, Neuron 39:889-909, 2003. (Pubitemid 37130207)
3. Sherer TB, Betarbet R, Stout AK, Lund S, Baptista, Panov AV, Cookson MR, Greenamyre JT, An in vitro model of Parkinson's disease: Linking mitochondrial impairment to altered a-synuclein metabolism and oxidative damage, J Neurosci 22(1):7006-7015, 2002. (Pubitemid 35379158)
4. Lang AE, Lozano AM, Parkinson's disease - first of two parts, New Eng J Med 339(15):1044-1053, 1998.
5. Olanow CW, McNaught KSP, ubiquitin-proteasome system and Parkinson's disease, Mov Disord 21(11):1806-1823, 2006. (Pubitemid 44856478)
6. Polymeropoulos MH, Lavedan C, Leroy E., Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science 276:2045-2047, 1997. (Pubitemid 27443610)
7. Taylor JP, Hardy J, Fischbeck KH, Toxic proteins in neurodegenerative disease, Science 296:1991-1995, 2002. (Pubitemid 34627514)
8. Ross CA, Pickart CM, The ubiquitin-proteasone pathway in Parkinson's disease and other neurodegenerative diseases, Trends Cell Biol 14(12):703-711, 2004. (Pubitemid 39572556)
9. Chen Q, Thorpe J, Keller JN, a-synuclein alters proteasome function, protein synthesis, and stationary phase viability, J Biol Chem 280(34):30009-300017, 2006.
10. Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P, a-Synucleinopathy and selective dopaminergic loss in a rat lentiviral-based model of Parkinson's disease, PNAS 99:10813-10818, 2002.
11. Vila M, Przedborski S, Genetic clues to the pathogenesis of Parkinson's disease, Nature Med 58-62, 2004.
12. Abeliovich A, Schmitz Y, Farias I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JM, Armanini M, Ryan A, Hynes M, Phillips H, Sulzer D, Rosenthal A, Mice lacking a-synuclein display functional deficits in the nigrostriatal dopamine system, Neuron 25(2):239-252, 2000. (Pubitemid 30316525)
13. DauerW, Kholodilov N, Vila M, Trillat AC, Goodchild R, Larsen KE, Staal R, Tieu K, Schmitz Y, Yuan CA, Rocha M, Jackson-Lewis V, Hersch S, Sulzer D, Przedborski S, Burke R, Hen R, Resistance of a-synuclein null mice to the Parkinsonian neurotoxin, MPTP 99(22):13972-12974, 2002.
14. Kahle PJ, Haass C, How does parkin ligate ubiquitin to Parkinson's disease? EMBO 5(7):681-685, 2004.
15. Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T, Familial Parkinson's disease gene product, parkin, is a ubiquitin-protein ligase, Nature Gen 25:302-305, 2000. (Pubitemid 30437317)
16. Zhang Y, Gao J, Chung KKK, Huang H, Dawson VL, Dawson TM, Parkin functions as an E2-dependent ubiquitin protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1, PNAS 97(24):13354-13359, 2000.
17. Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, Vink L, Choi P,Wolozin B, Farrer M, Hardy J, Cookson MR, Parkin protects against the toxicity associated with mutant a-synuclein proteasome dysfunction selectively affects catecholaminergic neurons, Neuron 36(6):1007-1019, 2001. (Pubitemid 36044504)
18. Chiecanover A, Brundin P, The ubiquitin-proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg, Neuron 40:427-443, 2003.
19. Conway KA, Rochet JC, Bieganski RM, Lansbury PT, Kinetic stabilization of the a-synuclein protofibril by a dopamine-a-synuclein adduct, Science 294:1346-1349, 2001. (Pubitemid 33063102)
20. Glaser CB, Yamin G, Uversky VN, Fink AL, Methionine oxidation, a-synuclein and Parkinson's disease, Biochim Biophys Acta 1703:157-169, 2005. (Pubitemid 40170439)
21. Dematté L, Priami C, Romanel A, The BlenX Language: A tutorial, SFM 2008 LNCS, Vol. 5016, Springer-Verlag, Berlin, pp. 313-365, 2008.
22. Dematté L, Priami C, Romanel A, The Beta Workbench: A computational tool to study the dynamics of biological systems, Brief Bioinform 9(5):437-448, 2008.
23. Web page of Beta WB: Http://www.cosbi.eu/index.php/research/prototypes/ beta-wb.
24. Priami C, Algorithmic systems biology, Comm ACM 52:80-88, 2009.
25. Raichura A, Vali G, Gorin F, Dynamics modeling of a-synuclein aggregation for the sporadic and genetic forms of Parkinson's disease, Neuroscience 142:859-870, 2006. (Pubitemid 44508709)
26. Sneppen K, Lizana L, Jensen MH, Pigolotti S, Otzen D, Modeling proteasome dynamics in Parkinson's disease, Phys Biol 6:703-711, 2009.
27. Hattori H, Mizuno Y, Pathogenetic mechanisms of parkin in Parkinson's disease, Lancet 364:722-724, 2004.
28. Tsigelny I, Modelling the molecular basis of Parkinson's disease, SciDAC review 52-57, 2007.
29. Weissman AM, Themes and variations on ubiquitylation, Nat Rev Mol Cell Biol 2:169-178, 2001. (Pubitemid 33675741)
30. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P, Molecular Biology of the Cell, Garland Science Taylor & Francis, New York, 2002.
31. Cappai R, Leck SL, Tew DJ, Williamson NA, Smith DP, Galatis D, Sharples RA, Curtain CC, Ali FE, Cherny RA, Culvenor FG, Bottomley SP, Masters CL, Barnham KJ, Hill AF, Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway, FASEB J 19:1377-1379, 2005. (Pubitemid 41113755)
32. Lindersson E, Beedholm R, Horup P, Moos T, Gai W, Hendil KB, Jensen PH, Proteasomal inhibition by alpha-synuclein filaments and oligomers, J Biol Chem 279, 2004.
33. Ii K, Ito H, Tanaka K, Hirano A, Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly, J Neuropathol Exp Neurol 56:156-131, 1997.
34. Jung T, Bader N, Grune T, Oxidized proteins: Intracellular distribution and recognition by the proteasome, Arch Biochem Biophys 462:231-237, 2007. (Pubitemid 46856318)
35. Horowitz JM, Vernace VA, Myers J, Stachowiakb MK, Hanlond DW, Fraleye GS, Torres G, Immunodetection of Parkin protein in vertebrate and invertebrate brains: A comparative study using specific antibodies, J Chem Neuroanat 21(1):75-93, 2001. (Pubitemid 32155393)
36. Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ, Ubiquitination of a new form of a-synuclein by parkin from human brain: Implications for Parkinsons disease, Science 293:268-269, 2001.
37. Imai Y, Soda M, Takahashi R, Pathologic and biochemical studies of juvenile Parkinsonism linked to chromosome 6q, Neurology 51:890-892, 1998.
38. Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, Takahashi R, An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin, Cell 105:891-902, 2001. (Pubitemid 32635090)
39. Shimura H, Hattori N, Kubo S, Yoshikawa M, Kitada T, Matsumine H, Asakawa S, Minoshima S, Yamamura Y, Shimizu N, Mizuno Y, Immunohistochemical and subcellular localization of Parkin protein: Absence of protein in autosomal recessive juvenile Parkinsonism patients, Ann Neurol 45:668-672, 1999. (Pubitemid 29217599)
40. Degano P, Prandi D, Priami C, Quaglia P, Beta binders for biological quantitative experiments, ENTCS 164(3):101-117, 2006. (Pubitemid 44584824)
41. Priami C, Quaglia P, Operational patterns in beta-binders, Trans Comput Sys Biol I 3380, 2005.
42. Priami C, Quaglia P, Beta binders for biological interactions, in Procs of CMSB 2004, LNCS 3082, 2005.
43. CoSBi Web Page: Http://www.cosbi.eu/index.php/research/prototypes/ overview.
44. Priami C, Stochastic p-calculus, Comp J 38(6):578-589, 1995.
45. Gillespie DT, Exact stochastic simulation of coupled chemical reactions, J Phys Chem 81(25):2340-2361, 1977.
46. Ferreon FCM, Gambin Y, Lemke EA, Deniz AA, Interpaly of a-synuclein binding and conformational switching probed by single-molecule fluorescence, PNAS 106(14):5645-5650, 2009.